ArticleInternational journal of oncology2020

Although c‑MYC contributes to tamoxifen resistance, it improves cisplatin sensitivity in ER‑positive breast cancer.

Rui Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.